Obstetrical Impact of Anti-MUT (Anti-MNS35) Alloimmunization

Mathilde Gavillet1,2, Tobias Gleich-Nagel1, Helene Legardeur3

  • 1Interregional Blood Transfusion SRC Bern Ltd., Bern, Switzerland.

Summary

Maternal alloimmunization against the rare MUT antigen can cause severe hemolytic disease of the fetus and newborn (HDFN). Early identification and multidisciplinary management are crucial for successful pregnancy outcomes in cases of rare red blood cell alloimmunization.